SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michail Shadkin who wrote (2262)6/16/2001 4:52:08 PM
From: jjs_ynot  Read Replies (1) of 6873
 
What is amazing is all of this enthusiasmabout IMNR (REMUNE) based on a report from some Bulletin Board company about an obscure Southeast Asian study with obviously no controls or peer review.

This is just after controlled clinical trials in Spain (where the controls are much more liberal than the US) showed no efficacy, even to the most liberal 20 percent confidence standard. That is, conclusive evidence of no effect.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News